DOWNLOAD REQUEST – FCF LIFE SCIENCES RESEARCH SERIES

FCF Life Sciences engages in research on recent financing trends in the Life Sciences sector, i.e. biotechnology, pharma and med-tech. FCF primarily focuses on the latest activities in the equity capital markets: Venture Capital, Initial Public Offerings (IPO) and Equity Valuations.

The findings are regularly published in:

Bitte füllen Sie das Pflichtfeld aus.

Salutation

Bitte füllen Sie das Pflichtfeld aus.

Titel

Like Dr., Prof. ...

Bitte füllen Sie das Pflichtfeld aus.

First name

Bitte füllen Sie das Pflichtfeld aus.

Last name

Bitte füllen Sie das Pflichtfeld aus.

E-Mail

Bitte füllen Sie das Pflichtfeld aus.

Position

Bitte füllen Sie das Pflichtfeld aus.

Company

Consent to be contacted

FCF Fox Corporate Finance GmbH (FCF) uses the information in this form to stay in touch with you and to inform you about events and latest market analyses.

Please fill mandatory field

Yes, I agree to be contacted by FCF.*

Bitte füllen Sie das Pflichtfeld aus.

Yes, I agree that FCF can contact me via E-Mail for the purposes of data maintenance.

I agree that for the stated purposes my data will be electronically processed by FCF. I can revoke this consent at any moment in time - without reasoning - and cancel the receipt of the FCF News with immediate effect. FCF will treat my data confidentially and will not disclose it to third parties.

Please fill mandatory field

Yes, I agree with the data protection provisions of FCF.

Learn more about our privacy policy.
* Mandatory fields

** All information and market analyses published by FCF are exclusively directed to and for the use by current and potential institutional clients, partners and investors. FCF retains the right to reject your request. To verify your request, we therefore need qualified details for the required fields.

NEWS & PRESS

FCF Life Sciences Venture Capital Report – 2020 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Report – 2020”. The Venture Capital Report, part of FCF Life Sciences Research Series, is the most detailed and

February 24, 2021

FCF Life Sciences Venture Capital Monitor – Europe 01/2021 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 01/2021”. The Monitor is a monthly published overview of venture capital trends in the European Life

February 18, 2021

FCF Biotech Venture Capital Monitor – USA 01/2021 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 01/2021”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As

February 16, 2021

FCF Life Sciences Venture Capital Monitor – Europe 12/2020 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 12/2020”. The Monitor is a monthly published overview of venture capital trends in the European Life

January 18, 2021

Dr. Joachim Greuel is the latest expert to join the Life Sciences Advisory Board at FCF Fox Corporate Finance GmbH

Complementing the leading industry experts already advising the Munich-based corporate financing specialist, Dr. Joachim Greuel joins FCF’s Life Sciences Advisory Board. Munich, January 18, 2021 FCF Fox Corporate Finance GmbH (“FCF”) welcomes yet another renowned

January 18, 2021